Khaled Machaca enjoys the high-risk, high-reward aspects of a start-up project. His latest is particularly demanding. Machaca has been tasked with establishing a research programme at a newly founded medical college in Qatar: a small Middle Eastern country whose science enterprise, initiated only in the past decade, is itself a start-up of sorts.
The challenges are manifold. Machaca has had to convince funders, the larger medical community and the public of the importance of his work. He has also had to source lab equipment in a place with few suppliers. To foster international collaborations, crucial to Qatari researchers' success, he has had to help craft and customize a code of research ethics, created by Qatar's Supreme Council of Health, that complies with both US and Qatari laws. And he has had to convince young scientists that they can advance their careers and conduct cutting-edge science in a country known less for research than for hosting the news network Al-Jazeera and, as was announced this month, the 2022 soccer World Cup.
“We had serious challenges,” says Machaca, who is associate research dean at Weill Cornell Medical College in Qatar (WCMC–Q), based in Doha. But he relishes the notion of building a programme from scratch. And the country has a big advantage: money. Scientists working in Qatar will find good funding and ample opportunities for big projects, but, like Machaca, they might have to deal with rigid bureaucracy, evolving research-ethics regulations and rules — on stem-cell research, for example — that could limit collaborative ventures. These trade-offs will help to determine Qatar's success as it attempts to build a sustainable science enterprise. >>>
A full, printer-friendly version of the story here.
--
No comments:
Post a Comment